A detailed history of Bruce G. Allen Investments, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 3,405 shares of BMY stock, worth $200,145. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,405
Previous 2,791 22.0%
Holding current value
$200,145
Previous $116 Million 51.99%
% of portfolio
0.14%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$39.66 - $51.75 $24,351 - $31,774
614 Added 22.0%
3,405 $176 Million
Q2 2024

Jul 12, 2024

SELL
$40.25 - $52.99 $27,933 - $36,775
-694 Reduced 19.91%
2,791 $116 Million
Q1 2024

Apr 10, 2024

BUY
$47.98 - $54.4 $35,121 - $39,820
732 Added 26.59%
3,485 $189 Million
Q4 2023

Jan 10, 2024

BUY
$48.48 - $57.85 $133,465 - $159,261
2,753 New
2,753 $141 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.